Trial Details
COMPLETEDBasic Information
| Clinical ID | c924 |
|---|---|
| Identifier | NCT01482884 |
| Trial Title | Evaluation of Efficacy and Safety of Tralokinumab in Patients With Active, Moderate-to-severe Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: tralokinumab|DRUG: placebo |
Participant Information
| Sponsor | AstraZeneca |
|---|---|
| City | Ceske Budejovice |
| Country/Region | Czech Republic |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-03-12 |
|---|---|
| Primary Completion Date | 2025-03-13 |
| Completion Date | 2025-06-13 |